Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedside.

Kuçi S, Henschler R, Müller I, Biagi E, Meisel R.

Stem Cells Int. 2012;2012:185943. doi: 10.1155/2012/185943. Epub 2012 Aug 28. No abstract available.

2.

Concise review: multipotent mesenchymal stromal cells in blood.

He Q, Wan C, Li G.

Stem Cells. 2007 Jan;25(1):69-77. Epub 2006 Sep 14. Review.

3.

Immunosuppressive effects of multipotent mesenchymal stromal cells in cultures with different O2 content in the medium.

Gornostaeva AN, Andreeva ER, Andrianova IV, Buravkova LB.

Bull Exp Biol Med. 2011 Aug;151(4):526-9.

PMID:
22448382
4.

Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: basic science to clinical translation.

Kagami H, Agata H, Tojo A.

Int J Biochem Cell Biol. 2011 Mar;43(3):286-9. doi: 10.1016/j.biocel.2010.12.006. Epub 2010 Dec 13. Review.

PMID:
21147252
5.

Study of growth parameters and potentialities of differentiation of multipotent mesenchymal stromal cells from rat bone marrow in vitro.

Sergeeva NS, Sviridova IK, Kirsanova VA, Akhmedova SA, Marshutina NV, Sergeeva VS, Bednik DY.

Bull Exp Biol Med. 2006 Apr;141(4):530-5.

PMID:
17152386
6.

Assessment of presence and characteristics of multipotent stromal cells in human endometrium and decidua.

Kyurkchiev S, Shterev A, Dimitrov R.

Reprod Biomed Online. 2010 Mar;20(3):305-13. doi: 10.1016/j.rbmo.2009.12.011. Epub 2009 Dec 16. Review.

PMID:
20117049
7.

Application of multipotent mesenchymal stromal cells from human adipose tissue for compensation of neurological deficiency induced by 3-nitropropionic Acid in rats.

Kulikov AV, Stepanova MS, Stvolinsky SL, Hudoerkov RM, Voronkov DN, Rzhaninova AA, Goldstein DV, Boldyrev AA.

Bull Exp Biol Med. 2008 Apr;145(4):514-9.

PMID:
19110607
8.

Assessment of DNA damage in human bone marrow cells and multipotent mesenchymal stromal cells.

Nikitina VA, Chausheva AI, Zhanataev AK, Osipova EY, Durnev AD, Bochkov NP.

Bull Exp Biol Med. 2011 Aug;151(4):550-2.

PMID:
22448389
9.

Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.

Reinders ME, Fibbe WE, Rabelink TJ.

Nephrol Dial Transplant. 2010 Jan;25(1):17-24. doi: 10.1093/ndt/gfp552. Epub 2009 Oct 26. Review.

PMID:
19861311
10.
11.

Study of genetic stability of human bone marrow multipotent mesenchymal stromal cells.

Nikitina VA, Osipova EY, Katosova LD, Rumyantsev SA, Skorobogatova EV, Shamanskaya TV, Bochkov NP.

Bull Exp Biol Med. 2011 Mar;150(5):627-31.

PMID:
22235401
12.

Trafficking of multipotent mesenchymal stromal cells from maternal circulation through the placenta involves vascular endothelial growth factor receptor-1 and integrins.

Chen CP, Lee MY, Huang JP, Aplin JD, Wu YH, Hu CS, Chen PC, Li H, Hwang SM, Liu SH, Yang YC.

Stem Cells. 2008 Feb;26(2):550-61. Epub 2007 Nov 1.

13.

The myelopoietic supportive capacity of mesenchymal stromal cells is uncoupled from multipotency and is influenced by lineage determination and interference with glycosylation.

Morad V, Pevsner-Fischer M, Barnees S, Samokovlisky A, Rousso-Noori L, Rosenfeld R, Zipori D.

Stem Cells. 2008 Sep;26(9):2275-86. doi: 10.1634/stemcells.2007-0518. Epub 2008 Jun 12.

15.

The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering.

Pytlík R, Stehlík D, Soukup T, Kalbácová M, Rypácek F, Trc T, Mulinková K, Michnová P, Kideryová L, Zivný J, Klener P Jr, Veselá R, Trnený M, Klener P.

Biomaterials. 2009 Jul;30(20):3415-27. doi: 10.1016/j.biomaterials.2009.03.001. Epub 2009 Apr 10.

PMID:
19362364
16.

Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa.

Dominici M, Paolucci P, Conte P, Horwitz EM.

Transplantation. 2009 May 15;87(9 Suppl):S36-42. doi: 10.1097/TP.0b013e3181a283ee.

PMID:
19424002
17.

Expanding autologous multipotent mesenchymal bone marrow stromal cells.

Brinchmann JE.

J Neurol Sci. 2008 Feb 15;265(1-2):127-30. Epub 2007 Jun 8. Review.

PMID:
17560612
18.

Lifespan of human amniotic fluid-derived multipotent mesenchymal stromal cells.

Miranda-Sayago JM, Fernández-Arcas N, Benito C, Reyes-Engel A, Carrera J, Alonso A.

Cytotherapy. 2011 May;13(5):572-81. doi: 10.3109/14653249.2010.547466. Epub 2011 Jan 5.

PMID:
21208022
19.

First-trimester human decidua contains a population of mesenchymal stem cells.

Dimitrov R, Kyurkchiev D, Timeva T, Yunakova M, Stamenova M, Shterev A, Kyurkchiev S.

Fertil Steril. 2010 Jan;93(1):210-9. doi: 10.1016/j.fertnstert.2008.09.061. Epub 2008 Nov 11.

PMID:
19006798
20.

Human multipotent mesenchymal stromal cells from distinct sources show different in vivo potential to differentiate into muscle cells when injected in dystrophic mice.

Vieira NM, Zucconi E, Bueno CR Jr, Secco M, Suzuki MF, Bartolini P, Vainzof M, Zatz M.

Stem Cell Rev. 2010 Dec;6(4):560-6. doi: 10.1007/s12015-010-9187-5.

PMID:
20821076

Supplemental Content

Support Center